Nanoform wins CPhI Excellence in Pharma Award for Formulation

The award recognises proprietary CESS nanonisation technology

picture of

Breaking News

Fujifilm plans major US gene therapy facility as part of $120m investment

The investment will include the construction of new cGMP facilities in the US to support CDMO services in the sector

Mesa Labs acquires Gyros Protein Technologies

The US-based quality control instrument supplier has acquired the Swedish protein synthesis solutions provider to begin ...

Cryoport joins Lonza vein-to-vein delivery network

Partnership in cell and gene therapy to provide global and fully integrated delivery solutions from manufacturing to ...

CPhI Annual Report foresees massive shortfalls in ATP production and bio capacity growth in China

A shortage of qualified personnel may be a drag factor in cell and gene therapies yet in China, 100,00L of capacity ...

Cesca Therapeutics changes name to match new focus

The newly named ThermoGenesis has moved from automated cell separation and cryostorage technologies into cell ...

Synthetic biology company moves to Cambridge business park in the UK

UK-based gene synthesis specialist Evonetix is developing a desktop DNA synthesis platform based on a proprietary ...

Medical cannabis made in Italy

Dr Fabio Di Francesco, a compounding pharmacist based in Rome, describes how cannabis is used in medicinal formulations ...

CPhI releases concluding report on trends in biologics

Dawn Ecker and Emil Ciurczak discuss regional growth, addressing new toxic by-products, contracting opportunities, and ...

CPhI Worldwide reveals finalists for 2019 Awards

The categories are API Development, formulation, manufacturing technology & equipment, bioprocessing, analysis & ...

Continuous bioprocessing: Can your tubing handle the pressure?

Extra strain is on pharmaceutical equipment as a result of the simultaneous rise of single-use components and ...

Future market dynamics and opportunities in immuno-oncology

Long-term survival, tumour-agnostic effects and the potential for cure in a fraction of patients are key catalysts ...

Rapid, automated at-line antibody titre measurements advance biopharmaceutical production

Biotherapeutic production relies on robust cell lines with reproducible growth, titre and quality, so determining the ...

Sanofi opens its first digitally enabled continuous manufacturing facility

The biologics manufacturing facility in Framingham, Massachusetts, uses paperless and data-driven manufacturing ...

Contract win sees Lonza develop and manufacture gene therapies for Prevail

New York-based Prevail Therapeutics has chosen the Swiss CDMO for GMP manufacturing of the AAV9-based gene therapy for ...